Shandong Intco Medical Products Co Ltd - Asset Resilience Ratio
Shandong Intco Medical Products Co Ltd (300677) has an Asset Resilience Ratio of 31.63% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shandong Intco Medical Products Co Ltd (300677) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Shandong Intco Medical Products Co Ltd's Asset Resilience Ratio has changed over time. See 300677 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shandong Intco Medical Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shandong Intco Medical Products Co Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥12.64 Billion | 31.63% |
| Total Liquid Assets | CN¥12.64 Billion | 31.63% |
Asset Resilience Insights
- Very High Liquidity: Shandong Intco Medical Products Co Ltd maintains exceptional liquid asset reserves at 31.63% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shandong Intco Medical Products Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Intco Medical Products Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Shandong Intco Medical Products Co Ltd (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Shandong Intco Medical Products Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 19.46% | CN¥6.74 Billion ≈ $985.90 Million |
CN¥34.63 Billion ≈ $5.07 Billion |
+16.78pp |
| 2023-12-31 | 2.67% | CN¥723.21 Million ≈ $105.83 Million |
CN¥27.08 Billion ≈ $3.96 Billion |
-4.89pp |
| 2022-12-31 | 7.56% | CN¥1.62 Billion ≈ $237.64 Million |
CN¥21.48 Billion ≈ $3.14 Billion |
-8.31pp |
| 2021-12-31 | 15.88% | CN¥3.27 Billion ≈ $479.12 Million |
CN¥20.62 Billion ≈ $3.02 Billion |
+5.20pp |
| 2020-12-31 | 10.68% | CN¥1.38 Billion ≈ $202.08 Million |
CN¥12.93 Billion ≈ $1.89 Billion |
+2.06pp |
| 2019-12-31 | 8.62% | CN¥257.90 Million ≈ $37.74 Million |
CN¥2.99 Billion ≈ $437.82 Million |
-- |
About Shandong Intco Medical Products Co Ltd
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers gloves; face masks; isolation gown, lab coat/jacket, and scrub suit; aldult and pe… Read more